SAO Equity Snapshot

B1ME34 Weekly Equity Report

BeOne Medicines AG

Interactive chart JSON snapshot
Latest Close 54.98 BRL 12 Jun 2026
1W Return -2.1% latest completed week
4W Return -11.6% short-term follow-through
12W Return -11.2% quarterly tape
Trend Breadth 71.2% 37 of 52 weeks active
Volume Ratio 0.1x vs 13-week average
Company Brief

What the company does

BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company's commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton's Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; SYLVANT for the treatment of adult patients with multicentric castleman disease; BAITUOWEI for patients with BC in premenopausal and perimenopausal women, and cancer; and PARTRUVIX for the treatment of various solid tumors. Its …

Snapshot

What the weekly tape is saying

B1ME34 closed the latest completed week at 54.98 BRL. The 4-week return is -11.6% and the 12-week return is -11.2%. Trend Signal is inactive, Market Dynamics is -0.94. Setup signature: Risk-first tape with a 21/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -16.4%
Volume 0.1x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 39 Persistence of active Trend Signal over the last year and current streak.
Momentum 13 Blend of 4-week and 12-week follow-through.
Dynamics 35 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 2 Participation compared with the 13-week volume baseline.
Risk Control 36 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
65.73 BRL
Vs Trend Line
-16.4%
Fair Value
49.52 BRL
Vs Fair Value
11.0%
52W High
72.73 BRL
52W Low
52.60 BRL
Drawdown
-24.4%
Range Position
11.8%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -2.1%
4W -11.6%
12W -11.2%
26W -21.5%
52W -10.9%

Trend read

Active Streak
0 weeks
52W Active Weeks
37
52W Active Breadth
71.2%
Sector Scope
BR Healthcare
Sector Rank
68 of 80
Sector Percentile
15.2%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.94
4W MD Change
21.8%
Relative Strength
-22.31
4W RS Change
-36.8%
Expectation
Negative
Probability
29.14%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
1
13W Average
18
52W Average
127
Vs 13W
0.1x
Vs 52W
0.0x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
2.5%
52W Volatility
3.8%
Upside Weeks
13
Downside Weeks
11
Downside Breadth
21.2%
Avg Gain / Loss
3.8% / -5.2%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
SAO
Country
BR
Sector
Healthcare
Industry
Biotechnology
Currency
BRL
Market Cap
153.7B

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.
  • Latest weekly return ranks in the weaker part of its sector group.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 54.98 BRL -2.1% 65.73 BRL 49.52 BRL -0.94 -22.31 1 Off
5 Jun 2026 56.16 BRL -5.2% 66.12 BRL 49.42 BRL -0.89 -20.13 1 Off
29 May 2026 59.24 BRL -4.7% 66.46 BRL 49.33 BRL -0.96 -18.37 1 Off
22 May 2026 62.16 BRL 0.0% 66.88 BRL 49.23 BRL -1.05 -15.69 0 Off
15 May 2026 62.16 BRL 5.1% 67.21 BRL 49.14 BRL -1.20 -16.31 3 Off
8 May 2026 59.16 BRL -1.1% 67.53 BRL 49.04 BRL -1.32 -23.39 160 Off
1 May 2026 59.80 BRL -3.4% 67.96 BRL 48.97 BRL -1.32 -24.13 62 Off
24 Apr 2026 61.93 BRL 0.0% 68.34 BRL 48.90 BRL -1.33 -23.12 0 Off
17 Apr 2026 61.93 BRL 0.0% 68.68 BRL 48.83 BRL -1.36 -25.34 0 Off
10 Apr 2026 61.93 BRL 0.0% 68.97 BRL 48.77 BRL -1.40 -26.27 0 Off
3 Apr 2026 61.93 BRL 0.0% 69.25 BRL 48.71 BRL -1.28 -22.95 0 Off
27 Mar 2026 61.93 BRL 0.0% 69.44 BRL 48.62 BRL -1.15 -20.66 0 Off
20 Mar 2026 61.93 BRL 0.0% 69.63 BRL 48.50 BRL -0.86 -18.63 0 Off
13 Mar 2026 61.93 BRL -7.9% 69.82 BRL 48.41 BRL -0.51 -19.62 2.7K Off